LogoCrystal's MCW Coder Hub

H59.032

13 min read

H59.032 — Cystoid Macular Edema following Cataract Surgery, Left Eye

Code Overview

H59.032 is a billable ICD-10-CM code for cystoid macular edema (CME) following cataract surgery, left eye. It is the left-eye counterpart to H59.031 and belongs to the H59.03 subcategory within the H59 category for intraoperative and postprocedural complications and disorders of the eye and adnexa, not elsewhere classified. This condition is also widely known as Irvine-Gass syndrome or pseudophakic cystoid macular edema (PCME).

Full Code Description

ElementDetail
Full CodeH59.032
DescriptionCystoid macular edema following cataract surgery, left eye
SynonymsIrvine-Gass syndrome (OS), PCME (OS), pseudophakic CME (left), aphakic CME (left), postoperative CME (left)
BillableYes
ICD-9-CM Approximate Equivalent362.53 — Cystoid macular degeneration (approximate, limited mapping)
Chapter7 — Diseases of the Eye and Adnexa
BlockH55-H59 — Other disorders of eye and adnexa
CategoryH59 — Intraoperative and postprocedural complications and disorders of eye and adnexa, NEC
LateralityLeft eye
Valid FYFY2025 (Oct 1, 2024 - Sep 30, 2025)

Clinical Description

Cystoid macular edema following cataract surgery is among the most common causes of reduced vision after an otherwise uncomplicated cataract procedure. It occurs when inflammatory mediators — principally prostaglandins and other arachidonic acid metabolites — disrupt the blood-retinal barrier, causing fluid to leak into the outer plexiform and inner nuclear layers of the macula. This fluid accumulates in characteristic cystic spaces arranged in a petalloid pattern centered on the fovea.

Pathophysiology and mechanism:

The inflammatory cascade begins with surgical manipulation of ocular tissues and is amplified by light energy from the operating microscope. Prostaglandins and cytokines are released, increasing vascular permeability in the perifoveal capillary plexus. As fluid accumulates intercellularly in the macula, the retina thickens, disrupting photoreceptor alignment and reducing visual acuity. Vitreous traction (if vitreous loss or incarceration in the wound occurred during surgery) can compound inflammation and worsen or perpetuate the edema.

Common precipitating and risk factors:

  • Surgical complications: posterior capsule rupture, vitreous loss, vitreous incarceration in the wound

  • Pre-existing ocular comorbidities: diabetic retinopathy, uveitis, retinal vascular occlusion, epiretinal membrane

  • Systemic factors: poorly controlled diabetes mellitus, autoimmune/inflammatory conditions

  • Prostaglandin analogs (used for glaucoma) — known to increase risk of CME post-cataract

  • Prior episodes of CME in the fellow eye

  • Sequential bilateral cataract surgery (CME may develop in the second operative eye after manifestation in the first)

  • Increased surgical time, phacoemulsification energy, or technical difficulty

Clinical features and timeline:

  • Most commonly develops 4-12 weeks postoperatively

  • Presents with painless blurred or distorted central vision, typically in a patient whose initial postoperative vision was good

  • Metamorphopsia (wavy distortion), reduced color saturation, micropsia

  • May follow a mild self-limiting course or become chronic and persistent (> 3 months = chronic CME)

  • Recurrence after initial resolution is possible, especially in high-risk patients

Diagnostic evaluation:

  • Optical coherence tomography (OCT): Gold standard — demonstrates increased central subfield thickness, intraretinal cystoid spaces, disorganization of retinal layers, and occasionally subretinal fluid

  • Fluorescein angiography (FA): Classic petalloid leakage pattern centered on the fovea; disc leakage may also be seen (as in Irvine-Gass)

  • Slit lamp biomicroscopy: May reveal loss of foveal reflex, cystic macular changes (in severe cases)

  • Visual acuity testing: Decreased BCVA, often disproportionate to apparent extent of cataract removed

Code Structure / Code Tree

H00-H59    Diseases of the Eye and Adnexa
  └── H55-H59    Other disorders of eye and adnexa
        └── H59    Intraoperative and postprocedural complications and disorders of eye and adnexa, NEC
              └── H59.0    Disorders of the eye following cataract surgery
                    ├── H59.00    Vitreous (touch) syndrome
                    ├── H59.01    Keratopathy (bullous aphakic) following cataract surgery
                    ├── H59.02    Cataract (lens) fragments in eye following cataract surgery
                    ├── H59.03    Cystoid macular edema following cataract surgery    ◄ **SUBCATEGORY**
                    │     ├── [[H59.031]]    ... right eye
                    │     ├── H59.032    ... left eye                                 ◄ **THIS CODE**
                    │     ├── [[H59.033]]    ... bilateral
                    │     └── [[H59.039]]    ... unspecified eye
                    └── H59.09    Other disorders of eye following cataract surgery

Important

Laterality at 5th character: H59.032 is a 5-character billable code — laterality is captured at the 5th character and no further extensions or 7th character are required or accepted.

Includes / Excludes Notes

Includes (H59 Category)

  • Intraoperative and postprocedural complications specific to ophthalmic procedures, not elsewhere classified

  • Post-cataract inflammatory macular complications

  • CME occurring in the context of aphakic or pseudophakic status following cataract extraction

Excludes1 (H59 Category — Mutually Exclusive; Do Not Code Together)

These codes cannot be reported simultaneously with H59.032 when the condition is the primary problem driving the encounter:

CodeDescriptionRationale
T85.2Mechanical complication of intraocular lensIf the root problem is IOL dislocation, malposition, or opacification, code T85.2 instead
T85.3Mechanical complication of other ocular prosthetic devices, implants and graftsDevice-related mechanical issues
Z96.1PseudophakiaStatus code only; not a complication code
H26.4-Secondary cataracts (posterior capsular opacification)Separate distinct post-cataract condition

Key Instructional Notes

  • When diabetes is documented and is potentially contributing to CME, code the diabetic condition additionally (e.g., E11.3- diabetes with ophthalmic complications) when documented and clinically supported, as separate disease contributions may warrant additional coding

  • External cause codes are generally not applied to H59.032 as this is a postprocedural/complication category, not a trauma code

  • Do not use H59.032 for non-post-cataract CME — if CME is from diabetic retinopathy, retinal vein occlusion, uveitis, or other etiology without a post-cataract connection, use the appropriate etiology-specific macular edema code

HCC (Hierarchical Condition Category) Mapping

H59.032 does NOT map to a CMS-HCC in any current risk adjustment model.

HCC ModelHCC AssignmentRAF Impact
CMS-HCC Model V28Not assignedNo RAF
RxHCC ModelNot assignedNo RAF
HHS-HCC (ACA Marketplace)Not assignedNo RAF

Note

Chronic Condition Awareness: Although H59.032 carries no RAF, it should always prompt the coder to evaluate whether underlying conditions that may be contributing (e.g., diabetes mellitus with ophthalmic complications, E11.311, which can map to HCC 18 in certain models) are properly captured and documented as monitored/managed during the encounter.

MS-DRG Mapping (Inpatient)

H59.032 almost exclusively appears in the outpatient setting (ophthalmology or retina clinic, ASC). If it were to serve as inpatient principal diagnosis:

MS-DRGDescriptionTrigger
124Other Disorders of the Eye with MCCH59.032 as PDx + MCC present
125Other Disorders of the Eye without MCCH59.032 as PDx, no MCC

MDC: MDC 02 — Diseases and Disorders of the Eye

CC/MCC Status:

  • H59.032 is not classified as a CC or MCC

  • Will not independently upgrade a DRG assignment when present as a secondary diagnosis

  • Inpatient admissions driven solely by isolated post-cataract CME are rare and would typically require clinical justification beyond routine CME management

CPT Procedure Codes (Commonly Associated)

Evaluation and Management

CPTDescriptionwRVU (approx.)
92004Comprehensive ophthalmological exam, new patient2.67
92014Comprehensive ophthalmological exam, established patient1.50
92012Intermediate ophthalmological exam, established patient0.97
99214Office visit, established patient, moderate complexity1.92
99213Office visit, established patient, low complexity1.30

Diagnostic Imaging

CPTDescriptionwRVU (approx.)
92134SCODI, posterior segment (OCT retina/RNFL) — used for CME monitoring and response to treatment0.58
92235Fluorescein angiography with interpretation and report1.10
92240Indocyanine-green (ICG) angiography with interpretation and report1.10

OCT coding note (CMS): For post-cataract CME, CMS has published coverage guidance supporting OCT (92134) with H59.032 as a covered diagnosis — this is an important documentation and coding link for LCD compliance.

Therapeutic / Procedural

CPTDescriptionwRVU (approx.)Assistant Allowed?
67028Intravitreal injection of a pharmacologic agent (anti-VEGF, steroid, NSAID)~1.60No
67025Injection of vitreous substitute, pars plana approach~3.50No
67500Retrobulbar injection (periocular corticosteroid)~0.61No
66821Discission of secondary membranous cataract (YAG laser capsulotomy), if PCO also present~3.44No

wRVU note:

Values listed are approximate. Always verify against the current-year CMS Physician Fee Schedule for your specific place of service (facility vs non-facility wRVUs are identical; total RVUs differ by PE component).

Assistant Surgeon Payable?

Service TypeAssistant Allowed?
E/M or ophthalmology exam (92004, 92014, 99213-99215)No — never payable for assistant
Diagnostic imaging (OCT, FA)No — diagnostic services do not permit assistant billing
Intravitreal injection (67028)No — office-based minor procedure
Periocular corticosteroid injection (67500)No — minor procedure
Major surgical procedures (if applicable)Verify per CPT against current MPFS assistant indicator

The routine management pathway for H59.032 does not involve assistant surgeon billing in any step. For complex surgical cases that may arise secondarily (e.g., pars plana vitrectomy for non-resolving CME with ERM), confirm assistant surgeon payment on a per-CPT basis with the current MPFS indicator.

Global Period Considerations and Modifier Guidance

This is one of the most important practical coding considerations for H59.032. Post-cataract CME often develops and requires treatment within the 90-day global period of the original cataract surgery. The following rules apply:

ScenarioModifierRationale
Intravitreal injection for CME, planned prior to surgery or anticipated as therapy-58Staged or related procedure; therapy following surgical procedure — initiates a new global period
Intravitreal injection for CME, unplanned, return to procedure room-78Related but unplanned return to procedure room during global period; paid at intraoperative component only (~80% of fee); does NOT initiate a new global period
Treatment by a different physician within the global period-79Unrelated procedure by same or different physician in global period — should be clearly documented as unrelated (rarely applicable for CME which is clearly related to cataract surgery)
Treatment performed after global period expiresNo modifier neededOutside global period; bill normally

Note

Modifier -78 vs -58: The critical distinction is whether the treatment was anticipated (pre-planned) = use -58 or unanticipated (new complication) = use -78. For CME arising unexpectedly after uncomplicated surgery, -78 is typically correct. If anti-VEGF injections were a planned postoperative therapeutic protocol, -58 applies. When in doubt, query the physician’s intent documented in the operative plan or postoperative note.

Coding Examples

Example 1 — Standard Post-Cataract CME, Conservative Management

Clinical Scenario:
A 66-year-old established patient had uncomplicated phacoemulsification with IOL implantation OS 5 weeks ago. She returns with complaints of blurry central vision and mild distortion in the left eye. BCVA is 20/60 OS. OCT demonstrates central subfield thickness of 410 µm with classic petalloid intraretinal cysts. Fluorescein angiography confirms perifoveal leakage. Diagnosis: pseudophakic cystoid macular edema (Irvine-Gass syndrome), left eye. Plan: initiate bromfenac ophthalmic solution 0.09% (Bromsite) BID OS and prednisolone acetate QID OS, follow up in 4 weeks.

ICD-10-CM:

  • H59.032 — Cystoid macular edema following cataract surgery, left eye

CPT:

  • 92014 — Comprehensive ophthalmological exam, established patient

  • 92134 — Scanning computerized ophthalmic diagnostic imaging, posterior segment (OCT)

  • 92235 — Fluorescein angiography with interpretation and report

Example 2 — CME Requiring Intravitreal Injection within Global Period

Clinical Scenario:
A 74-year-old patient underwent cataract surgery OS 7 weeks ago (global period active). He develops pseudophakic CME OS that fails to respond to topical therapy over 4 weeks. The surgeon performs an intravitreal injection of bevacizumab (off-label) for refractory CME. The injection was not planned preoperatively.

ICD-10-CM:

  • H59.032 — Cystoid macular edema following cataract surgery, left eye

CPT:

  • 92014 — Comprehensive ophthalmological exam, established patient

  • 92134 — OCT posterior segment

  • 67028-78-LT — Intravitreal injection of pharmacologic agent, modifier -78 (unplanned related procedure during global period), left eye modifier

Payer note: Modifier -78 reimburses at the intraoperative component only (~80% of the fee schedule amount). No new global period is initiated.

Example 3 — CME with Planned (Pre-Staged) Protocol Anti-VEGF Injection

Clinical Scenario:
A 58-year-old patient with diabetes (Type 2, mild NPDR) underwent cataract surgery OS. Given her high-risk profile, the surgeon documented in the preoperative plan that intravitreal anti-VEGF injections would be administered postoperatively if CME developed. CME is confirmed at the 6-week postop visit, and the planned injection series is initiated.

ICD-10-CM:

  • H59.032 — Cystoid macular edema following cataract surgery, left eye

  • E11.329 — Type 2 DM with mild nonproliferative diabetic retinopathy without macular edema (or more specific retinal code as documented)

CPT:

  • 92014 — Comprehensive ophthalmological exam

  • 92134 — OCT posterior segment

  • 67028-58-LT — Intravitreal injection, modifier -58 (staged/planned therapy following surgical procedure), left eye; initiates a new global period

Example 4 — Bilateral CME (Laterality Change)

Clinical Scenario:
A patient had sequential cataract surgery OU (right eye 3 months ago, left eye 6 weeks ago). CME now develops in both eyes simultaneously.

Correct ICD-10-CM:

  • H59.033 — Cystoid macular edema following cataract surgery, bilateral

Do not separately code H59.031 + H59.032 for bilateral involvement — use H59.033. Only code unilateral codes (H59.031 or H59.032) when a single eye is affected or when stages/severity differ and documentation supports separate lateralized coding.

Example 5 — Chronic Refractory CME, Vitreoretinal Referral

Clinical Scenario:
A 70-year-old patient has had persistent CME OS for 6 months post-cataract surgery despite multiple intravitreal steroid injections and topical NSAID therapy. OCT shows persistent cystic changes with central subfield thickness of 550 µm. An epiretinal membrane (ERM) is identified as a contributing factor. The patient is referred to a vitreoretinal surgeon for evaluation for pars plana vitrectomy with membrane peel.

ICD-10-CM:

  • H59.032 — Cystoid macular edema following cataract surgery, left eye

  • H35.372 — Epiretinal membrane, left eye

CPT (if vitrectomy and membrane peel performed):

  • 67041 — Vitrectomy, mechanical, pars plana approach; with removal of preretinal cellular membrane (e.g., macular pucker)

  • 92134 — OCT posterior segment (pre-op and follow-up)

Assistant surgeon: For 67041 (pars plana vitrectomy with membrane peel), verify the CPT’s assistant indicator in the current MPFS. Major vitreoretinal procedures may allow assistant surgeon billing (modifier -80 or -AS) depending on payer policy and the specific procedure’s assistant indicator.

Key Coding Pitfalls & Tips

  • Laterality compliance: H59.032 is for the left eye only. Avoid H59.039 (unspecified) when laterality is documented. The left eye is the OS; confirm laterality is clearly stated in the note before coding.

  • Bilateral coding: When both eyes develop CME post-cataract, use H59.033 (bilateral) — do not code H59.031 + H59.032 together.

  • Do not use for non-post-cataract CME: H59.032 is specifically for CME attributable to cataract surgery. CME from diabetic retinopathy (E11.311), retinal vein occlusion (H35.81-), or uveitis should be coded with the appropriate etiology-specific code.

  • Global period modifier selection is critical: Incorrect modifier choice (-58 vs -78) is a leading cause of denials and overpayment audits in retina/ophthalmology billing. Always confirm whether the treating physician planned the postoperative injection beforehand.

  • Excludes1 compliance: Never pair H59.032 with Z96.1 (pseudophakia), T85.2- (IOL mechanical complication), or H26.4- (secondary cataract) on the same claim when those codes represent the actual problem being treated.

  • Do not default to unspecified: H59.039 should be avoided when the left eye is clearly documented as the affected eye.

  • Diabetes CME vs post-cataract CME distinction: A diabetic patient who develops CME after cataract surgery should be coded to H59.032 as the primary post-cataract complication; however, the diabetes code should be added if it is documented as contributing. These are clinically related and the coding should reflect the full clinical picture.

CodeDescription
H59.031Cystoid macular edema following cataract surgery, right eye
H59.033Cystoid macular edema following cataract surgery, bilateral
H59.039Cystoid macular edema following cataract surgery, unspecified eye
H59.021Cataract (lens) fragments in eye following cataract surgery, right eye
H59.022Cataract (lens) fragments in eye following cataract surgery, left eye
H59.012Keratopathy (bullous aphakic) following cataract surgery, left eye
H35.81Retinal edema (non-post-cataract; use when CME etiology is not post-surgical)
H35.372Epiretinal membrane, left eye
E11.311Type 2 DM with unspecified diabetic retinopathy with macular edema
H26.41Soemmering’s ring (secondary cataract — Excludes1; do not pair with H59.032)
T85.22XADisplacement of intraocular lens (IOL mechanical complication — Excludes1)
Z98.42Cataract extraction status, left eye (post-op status code, if applicable)

Last Reviewed: 2026-02-18 | Source: ICD-10-CM FY2025, CMS MPFS, CMS SCODI Coverage Article, AAO Retina Preferred Practice Pattern

Graph View

Recent Notes